Skip to content

Clinical trials

Lymphadenopathy trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphadenopathy Country / region: China Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20162
20201
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting2
Unknown status2
Completed1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bin Cheng1
Chinese PLA General Hospital1
Peking University Third Hospital1
Second Affiliated Hospital of Wenzhou Medical University1
Second Affiliated Hospital, Zhejiang University, School of Medicine1
Shanghai Chest Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphadenopathy6
Adnexal Diseases1
Immunoglobulin G4-Related Disease1
Infections1
Inflammation1
Leiomyoma1
Lymphatic Metastasis1
Lymphoma1
Mikulicz' Disease1
Neoplasm Metastasis1

Trials

Showing 26 to 6 of 6. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.